HealthTech

Orca Bio's T cell therapy may help blood cancer patient...

Orca Bio on Monday said its T cell therapy, when used in people with certain blo...

Health IT Potpourri Edition – Healthcare IT Today Podca...

For the 162nd episode of the Healthcare IT Today Podcast, we are doing a little ...

Vertanical’s Phase 3 win for non-opioid painkiller; Apr...

Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Su...

Fluency Isn’t Intelligence in Healthcare

The current wave of generative AI has captured public imagination, but we must t...

AstraZeneca spotlights first-in-human data for B7-H4-ta...

AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...

Kennedy's anti-vaccine actions shouldn't surprise anyone

At the end of Robert F. Kennedy Jr.'s confirmation hearing, Senate HELP Committe...

The Community Information Exchange: Accelerating Use of...

Steve Heard, Chief Innovation Officer at J2 Interactive, presents a strategy in ...

Better Science, Better Medicine: How Clinical Research ...

Modern trial designs, digital solutions and a deeper understanding of patient re...

Berry Street Raises $50M to Empower Dietitians to Lead ...

Berry Street, the leading nutrition counseling platform in the US has raised $50...

GRO Biosciences, working on recoded organisms, cuts mos...

GRO Biosciences, a small but ambitious biotech startup attempting to create nove...

Curevo gets $110M for a shot against Shingrix, gets Mon...

A Seattle biotech trying to take on one of the world’s biggest vaccines has nabb...

Otsuka's Taiho buys Swiss startup Araris with three ADC...

A small Swiss drug developer is being scooped up for its pipeline of three antib...

AstraZeneca reveals first-in-human data for B7-H4-targe...

AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...

HC Bioscience, a tRNA biotech backed by ARCH and Takeda...

A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug develop...

Avidity heads to FDA with exon 44 skipping Duchenne mus...

Avidity Biosciences shared Monday that its RNA drug for people with certain muta...

AstraZeneca to buy cell therapy startup EsoBiotec for $...

AstraZeneca said Monday that it has agreed to acquire a cell therapy biotech fou...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.